RecruitingPhase 1Phase 2

cfMSC Therapy for Diabetes

NCT07495956

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Shenzhen Geno-immune Medical Institute

Shenzhen, Guangdong, China

Contact

Lung-Ji Chang, ph.D